Literature DB >> 29395325

Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.

Hachung Chung1, Jorg J A Calis2, Xianfang Wu1, Tony Sun1, Yingpu Yu1, Stephanie L Sarbanes1, Viet Loan Dao Thi1, Abigail R Shilvock1, H-Heinrich Hoffmann1, Brad R Rosenberg3, Charles M Rice4.   

Abstract

Type I interferon (IFN) is produced when host sensors detect foreign nucleic acids, but how sensors differentiate self from nonself nucleic acids, such as double-stranded RNA (dsRNA), is incompletely understood. Mutations in ADAR1, an adenosine-to-inosine editing enzyme of dsRNA, cause Aicardi-Goutières syndrome, an autoinflammatory disorder associated with spontaneous interferon production and neurologic sequelae. We generated ADAR1 knockout human cells to explore ADAR1 substrates and function. ADAR1 primarily edited Alu elements in RNA polymerase II (pol II)-transcribed mRNAs, but not putative pol III-transcribed Alus. During the IFN response, ADAR1 blocked translational shutdown by inhibiting hyperactivation of PKR, a dsRNA sensor. ADAR1 dsRNA binding and catalytic activities were required to fully prevent endogenous RNA from activating PKR. Remarkably, ADAR1 knockout neuronal progenitor cells exhibited MDA5 (dsRNA sensor)-dependent spontaneous interferon production, PKR activation, and cell death. Thus, human ADAR1 regulates sensing of self versus nonself RNA, allowing pathogen detection while avoiding autoinflammation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADAR1; AGS; Aicardi-Goutieres syndrome; Alu elements; MDA5; PKR; RNA editing; innate immunity; neuronal progenitor cells; translation; type I interferon

Mesh:

Substances:

Year:  2018        PMID: 29395325      PMCID: PMC5831367          DOI: 10.1016/j.cell.2017.12.038

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  55 in total

Review 1.  Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase.

Authors:  Jean-François Gélinas; Guerline Clerzius; Eileen Shaw; Anne Gatignol
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

2.  An unwinding activity that covalently modifies its double-stranded RNA substrate.

Authors:  B L Bass; H Weintraub
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

Review 3.  Functions and regulation of RNA editing by ADAR deaminases.

Authors:  Kazuko Nishikura
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

4.  The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage.

Authors:  A D J Scadden
Journal:  Nat Struct Mol Biol       Date:  2005-05-15       Impact factor: 15.369

5.  An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells.

Authors:  Federico González; Zengrong Zhu; Zhong-Dong Shi; Katherine Lelli; Nipun Verma; Qing V Li; Danwei Huangfu
Journal:  Cell Stem Cell       Date:  2014-06-12       Impact factor: 24.633

6.  Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development.

Authors:  Kathleen Pestal; Cory C Funk; Jessica M Snyder; Nathan D Price; Piper M Treuting; Daniel B Stetson
Journal:  Immunity       Date:  2015-11-17       Impact factor: 31.745

7.  Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation.

Authors:  Xiaodi Su; Yingpu Yu; Yi Zhong; Eugenia G Giannopoulou; Xiaoyu Hu; Hui Liu; Justin R Cross; Gunnar Rätsch; Charles M Rice; Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2015-06-29       Impact factor: 25.606

8.  Detection of interferon alpha protein reveals differential levels and cellular sources in disease.

Authors:  Mathieu P Rodero; Jérémie Decalf; Vincent Bondet; David Hunt; Gillian I Rice; Scott Werneke; Sarah L McGlasson; Marie-Alexandra Alyanakian; Brigitte Bader-Meunier; Christine Barnerias; Nathalia Bellon; Alexandre Belot; Christine Bodemer; Tracy A Briggs; Isabelle Desguerre; Marie-Louise Frémond; Marie Hully; Arn M J M van den Maagdenberg; Isabelle Melki; Isabelle Meyts; Lucile Musset; Nadine Pelzer; Pierre Quartier; Gisela M Terwindt; Joanna Wardlaw; Stewart Wiseman; Frédéric Rieux-Laucat; Yoann Rose; Bénédicte Neven; Christina Hertel; Adrian Hayday; Matthew L Albert; Flore Rozenberg; Yanick J Crow; Darragh Duffy
Journal:  J Exp Med       Date:  2017-04-18       Impact factor: 14.307

9.  Ribonuclease L mediates the cell-lethal phenotype of double-stranded RNA editing enzyme ADAR1 deficiency in a human cell line.

Authors:  Yize Li; Shuvojit Banerjee; Stephen A Goldstein; Beihua Dong; Christina Gaughan; Sneha Rath; Jesse Donovan; Alexei Korennykh; Robert H Silverman; Susan R Weiss
Journal:  Elife       Date:  2017-03-31       Impact factor: 8.140

10.  Human endonuclease V is a ribonuclease specific for inosine-containing RNA.

Authors:  Yoko Morita; Toshihiro Shibutani; Nozomi Nakanishi; Kazuko Nishikura; Shigenori Iwai; Isao Kuraoka
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  162 in total

1.  Defining the Role of Stress Granules in Innate Immune Suppression by the Herpes Simplex Virus 1 Endoribonuclease VHS.

Authors:  Hannah M Burgess; Ian Mohr
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

Review 2.  Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses.

Authors:  Charles E Samuel
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

Review 3.  An Update on Autoinflammatory Diseases: Interferonopathies.

Authors:  Sophia Davidson; Annemarie Steiner; Cassandra R Harapas; Seth L Masters
Journal:  Curr Rheumatol Rep       Date:  2018-05-30       Impact factor: 4.592

Review 4.  Double-Stranded RNA Sensors and Modulators in Innate Immunity.

Authors:  Sun Hur
Journal:  Annu Rev Immunol       Date:  2019-01-23       Impact factor: 28.527

Review 5.  Structural Variability in the RLR-MAVS Pathway and Sensitive Detection of Viral RNAs.

Authors:  Qiu-Xing Jiang
Journal:  Med Chem       Date:  2019       Impact factor: 2.745

6.  Cell Type-Specific Transcriptomics Reveals that Mutant Huntingtin Leads to Mitochondrial RNA Release and Neuronal Innate Immune Activation.

Authors:  Hyeseung Lee; Robert J Fenster; S Sebastian Pineda; Whitney S Gibbs; Shahin Mohammadi; Jose Davila-Velderrain; Francisco J Garcia; Martine Therrien; Hailey S Novis; Fan Gao; Hilary Wilkinson; Thomas Vogt; Manolis Kellis; Matthew J LaVoie; Myriam Heiman
Journal:  Neuron       Date:  2020-07-17       Impact factor: 17.173

7.  RNA metabolism: Interfering with interferon by RNA editing.

Authors:  Eytan Zlotorynski
Journal:  Nat Rev Mol Cell Biol       Date:  2018-02-07       Impact factor: 94.444

Review 8.  A-to-I RNA editing - immune protector and transcriptome diversifier.

Authors:  Eli Eisenberg; Erez Y Levanon
Journal:  Nat Rev Genet       Date:  2018-08       Impact factor: 53.242

9.  Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade.

Authors:  Jeffrey J Ishizuka; Robert T Manguso; Collins K Cheruiyot; Kevin Bi; Arpit Panda; Arvin Iracheta-Vellve; Brian C Miller; Peter P Du; Kathleen B Yates; Juan Dubrot; Ilana Buchumenski; Dawn E Comstock; Flavian D Brown; Austin Ayer; Ian C Kohnle; Hans W Pope; Margaret D Zimmer; Debattama R Sen; Sarah K Lane-Reticker; Emily J Robitschek; Gabriel K Griffin; Natalie B Collins; Adrienne H Long; John G Doench; David Kozono; Erez Y Levanon; W Nicholas Haining
Journal:  Nature       Date:  2018-12-17       Impact factor: 49.962

Review 10.  Harnessing innate immunity in cancer therapy.

Authors:  Olivier Demaria; Stéphanie Cornen; Marc Daëron; Yannis Morel; Ruslan Medzhitov; Eric Vivier
Journal:  Nature       Date:  2019-10-02       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.